Category Archives: Indian Patent Law

Gilead Sciences, Inc.’s (GILD) Sovaldi Faces Patent Opposition In India

Source: BidnessEtc 3 Feb 2015 Gilead is looking at another pre-grant opposition to its patent application for Sovaldi in India, on the grounds of the drug being ineffective Gilead Sciences, Inc.’s (NASDAQ:GILD) patent application for its hepatitis C drug, Sovaldi – … Continue reading

Posted in access to medicines, Hepatitis - C, Indian Patent Law, Indian Patent Office, patent, Patent Opposition | Leave a comment

Indo-US joint statement after Obama-Modi talks

A joint statement released by India US on 25th Jan 2015 at New Delhi. Full Statement can be accessed here .Some of the excerpts from the statement committing on Intellectual Property and BITS: The President and the Prime Minister affirmed their shared … Continue reading

Posted in Indian Patent Law, Intellectual Property, Uncategorized, US India BIT | Leave a comment

Modi says ready to accept India-U.S. working group’s IPR suggestions

Source: Reuters 27 Jan 2015 India is ready to accept suggestions made by a joint working group with the United States on intellectual property rights, Prime Minister Narendra Modi told a conclave of Indian and U.S. corporate chiefs on Monday.

Posted in Indian Patent Law, IP Rights, IPR policy, patent | 1 Comment

India’s Patent Office Breaths New Life On The Production Of Hepatitis C Medication, Gilead Shot-Down In The Process

Source: The Science Times 22 Jan 2015 Hepatitis C is a blood-borne virus that’s often associated with pandemic like outbreaks in third-world countries, due to the viruse’s communicably when sterilization practices aren’t enforced. Once rampant inside the host’s body, the … Continue reading

Posted in access to medicines, Hepatitis - C, Indian Patent Law, Indian Patent Office, patent, Sofosbuvir | Leave a comment

Smart cities to investment treaties: What you should expect from Obama’s India visit

Source: Firstpost 21 Jan 2015 With US President Barack Obama scheduled to visit India on 25 January, preparations for the high-profile visit are entering final stages. India-US ties are set to move to a transformative level,  with talks on a range of … Continue reading

Posted in Indian Patent Law, IPR policy, patent, US India BIT, US pressure on India | Leave a comment

TAC, SECTION27 AND MSF APPLAUD INDIA’S REJECTION OF PATENT ON NEW HEPATITIS C MEDICINE

Source: TAC 20 Jan 2015 – The rejection of a patent on sofosbuvir will allow India to produce more affordable generic versions – South Africa’s outdated laws prevent patent rejection, which could lead to artificially high prices until 2034 JOHANNESBURG, … Continue reading

Posted in access to medicines, Hepatitis - C, Indian Patent Law, Indian Patent Office, patent, Sofosbuvir | Leave a comment

Missing: Intellectual Property Rights with a social lens

Source: India Together 20 Jan 2015 The Modi government has moved fast and furious on charting a new policy regarding intellectual property rights; Shalini Bhutani’s recap of recent developments shows that much of it has been with an overt focus … Continue reading

Posted in Indian Patent Law, IPR policy, US India BIT, US pressure on India | Leave a comment